Novel Sulfonamide Derivatives as Anticancer Agents, VEGFR‑2 Inhibitors, and Apoptosis Triggers: Design, Synthesis, and Computational Studies. [PDF]
Al-Ziyadi SH +9 more
europepmc +1 more source
Multimodal characterization of a pyrazolo[3,4-<i>b</i>]pyridine aldehyde: quantum chemical insights, NLO activity and VEGFR-2 docking/molecular dynamics. [PDF]
Acosta-Quiroga K +8 more
europepmc +1 more source
Development of the 5‑Nitrosalicaldehyde Arylhydrazones as Anticancer (MCF‑7 and HCT116) Agents Targeting Inhibition of VEGFR‑2 and Cytokines (IL‑6 and TNF-α). [PDF]
Nkoana JK +3 more
europepmc +1 more source
Pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as VEGFR-2 and EGFR<sup>T790M</sup> dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations. [PDF]
Aziz NAAM +4 more
europepmc +1 more source
Ajuforrestin A Inhibits Tumor Proliferation and Migration by Targeting the STAT3/FAK Signaling Pathways and VEGFR-2. [PDF]
Wang S +8 more
europepmc +1 more source
Sulfonamides a Promising Hit for Cancer Therapy Through VEGFR-2 Inhibition. [PDF]
Charissopoulos E, Pontiki E.
europepmc +1 more source
Novel pyrazole-oxadiazole-chalcone/oxime hybrids as dual EGFR/VEGFR-2 inhibitors with promising anticancer potential: a comprehensive cytotoxicity evaluation, mechanistic insights and SAR analysis. [PDF]
Alshazly O +3 more
europepmc +1 more source
Design, synthesis, and anticancer evaluation of novel pyrazole-thiophene hybrid derivatives as multitarget inhibitors of wild EGFR, mutant (T790M) EGFR, and VEGFR-2. [PDF]
Sallam MN +5 more
europepmc +1 more source
Design, synthesis, and characterization of novel 5-ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations. [PDF]
Al-Wahaibi LH +5 more
europepmc +1 more source
Synthesis, antiproliferative evaluation and <i>in silico</i> studies of new quinazoline derivatives as VEGFR-2 inhibitors. [PDF]
Abdelsalam Ouf AM +8 more
europepmc +1 more source

